Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2008, Article ID 587082, 7 pages
http://dx.doi.org/10.1155/2008/587082
Research Article

The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women

1Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Downstate, Brooklyn, NY 11219, USA
2Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461, USA
3Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, MD 20892, USA
4Department of Medicine, The University of California, San Francisco (UCSF), San Francisco, CA 94143, USA
5Department of Internal Medicine, University of Southern California School of Medicine, Los Angeles, CA 90033, USA
6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
7International Mailman School of Public Health, Columbia University, New York, NY 10032, USA
8Department of Medicine, School of Medicine, Georgetown University, Washington, DC 20007, USA
9Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794, USA
10Department of Pediatrics, Albert Einstein College of Medicine, Yeshiva University, 1400 Pelham Parkway South, Bronx, NY 10033, USA

Received 30 November 2007; Accepted 26 February 2008

Academic Editor: Harold Wiesenfeld

Copyright © 2008 Howard Minkoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Palefsky, H. Minkoff, L. A. Kalish et al., “Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women,” Journal of the National Cancer Institute, vol. 91, no. 3, pp. 226–236, 1999. View at Publisher · View at Google Scholar
  2. H. Minkoff, J. Feldman, J. DeHovitz, S. Landesman, and R. Burk, “A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women,” American Journal of Obstetrics and Gynecology, vol. 178, no. 5, pp. 982–986, 1998. View at Publisher · View at Google Scholar
  3. H. Minkoff, D. Matityahu, J. Feldman, R. Burk, and L. Clake, “Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus,” American Journal of Obstetrics and Gynecology, vol. 180, no. 4, pp. 824–836, 1999. View at Publisher · View at Google Scholar
  4. H. D. Strickler, R. Burk, M. Fazzari et al., “Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women,” Journal of the National Cancer Institute, vol. 97, no. 8, pp. 577–586, 2005. View at Publisher · View at Google Scholar
  5. T. V. Ellerbrock, M. A. Chiasson, T. J. Bush et al., “Incidence of cervical squamous intraepithelial lesions in HIV-infected women,” The Journal of the American Medical Association, vol. 283, no. 8, pp. 1031–1037, 2000. View at Publisher · View at Google Scholar
  6. L. Ahdieh, R. S. Klein, R. Burk et al., “Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women,” The Journal of Infectious Diseases, vol. 184, no. 6, pp. 682–690, 2001. View at Publisher · View at Google Scholar
  7. B. Gallagher, Z. Wang, M. J. Schymura, A. Kahn, and E. J. Fordyce, “Cancer incidence in New York State acquired immunodeficiency syndrome patients,” American Journal of Epidemiology, vol. 154, no. 6, pp. 544–556, 2001. View at Publisher · View at Google Scholar
  8. M.-N. Didelot-Rousseau, N. Nagot, V. Costes-Martineau et al., “Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso,” British Journal of Cancer, vol. 95, no. 3, pp. 355–362, 2006. View at Publisher · View at Google Scholar
  9. G. M. McQuillan, D. Kruszon-Moran, B. J. Kottiri et al., “Prevalence of HIV in the US household population: the national health and nutrition examination surveys, 1988 to 2002,” Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 5, pp. 651–656, 2006. View at Publisher · View at Google Scholar
  10. H. Minkoff, S. McCalla, I. Delke, R. Stevens, M. Salwen, and J. Feldman, “The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women,” American Journal of Obstetrics and Gynecology, vol. 163, no. 2, pp. 521–526, 1990. View at Google Scholar
  11. M.-L. Shen, Y. D. Luo, K. Hagen, Y. B. Wu, and D. Ou, “Immunomodulating activities of cocaine—evaluation of lymphocyte transformation related to other immune functions,” International Journal of Immunopharmacology, vol. 16, no. 4, pp. 311–319, 1994. View at Publisher · View at Google Scholar
  12. M. Starec, B. Rouveix, M. Sinet et al., “Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus,” The Journal of Pharmacology and Experimental Therapeutics, vol. 259, no. 2, pp. 745–750, 1991. View at Google Scholar
  13. A. H. Avila, C. A. Morgan, and B. M. Bayer, “Stress-induced suppression of the immune system after withdrawal from chronic cocaine,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 1, pp. 290–297, 2003. View at Publisher · View at Google Scholar
  14. P. Ruiz, T. Cleary, M. Nassiri, and B. Steele, “Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine,” Clinical Immunology and Immunopathology, vol. 70, no. 3, pp. 245–250, 1994. View at Publisher · View at Google Scholar
  15. G. C. Baldwin, M. D. Roth, and D. P. Tashkin, “Acute and chronic effects of cocaine on the immune system and the possible link to AIDS,” Journal of Neuroimmunology, vol. 83, no. 1-2, pp. 133–138, 1998. View at Publisher · View at Google Scholar
  16. M. R. Irwin, L. Olmos, M. Wang et al., “Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms,” Journal of Pharmacology and Experimental Therapeutics, vol. 320, no. 2, pp. 507–515, 2007. View at Publisher · View at Google Scholar
  17. G. Gekker, S. Hu, W. S. Sheng, R. B. Rock, J. R. Lokensgard, and P. K. Peterson, “Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-β1,” International Immunopharmacology, vol. 6, no. 6, pp. 1029–1033, 2006. View at Publisher · View at Google Scholar
  18. G. M. Clifford, J. Polesel, M. Rickenbach et al., “Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy,” Journal of the National Cancer Institute, vol. 97, no. 6, pp. 425–432, 2005. View at Publisher · View at Google Scholar
  19. S. E. Barkan, S. L. Melnick, S. Preston-Martin et al., “The women's interagency HIV study (WIHS)-design, methods, sample, cohort characteristics and comparison with reported AIDS cases in US women,” Epidemiology, vol. 9, pp. 117–125, 1998. View at Publisher · View at Google Scholar
  20. J. M. Palefsky, H. Minkoff, L. A. Kalish et al., “Cervicovaginal human papilloma virus infection in HIV-positive and high risk HIV-negative women,” Journal of the National Cancer Institute, vol. 91, no. 3, pp. 226–236, 1999. View at Publisher · View at Google Scholar
  21. R. Tachezy, M. A. Vanranst, Y. Cruz, and R. Burk, “Analysis of short novel human papillomavirus sequences,” Biochemical and Biophysical Research Communications, vol. 204, no. 2, pp. 820–827, 1994. View at Publisher · View at Google Scholar
  22. A. Hildesheim, M. H. Schiffman, P. E. Gravitt et al., “Persistence of type-specific human papillomavirus infection among cytologically normal women,” Journal of Infectious Diseases, vol. 169, no. 2, pp. 235–240, 1994. View at Google Scholar
  23. R. Burk, G. Y. Ho, L. Beardsley, M. Lempa, M. Peters, and R. Bierman, “Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women,” Journal of Infectious Diseases, vol. 174, no. 4, pp. 679–689, 1996. View at Google Scholar
  24. N. Muñoz, F. X. Bosch, S. de Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar
  25. R. J. Kurman and D. Solomon, The Bethesda System for Reporting Cervical/Vaginal Diagnoses, Springer, New York, NY, USA, 1994.
  26. H. Revets, D. Marissens, S. de Wit et al., “Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma,” Journal of Clinical Microbiology, vol. 34, no. 5, pp. 1058–1064, 1996. View at Google Scholar
  27. H. D. Strickler, J. M. Palefsky, and K. V. Shah, “Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women,” Journal of National Cancer Institute, vol. 95, no. 14, pp. 1062–1071, 2003. View at Google Scholar
  28. S. L. Zeger, K. Y. Liang, and P. S. Albert, “Models for longitudinal data: a generalized estimating equation approach,” Biometrics, vol. 44, no. 4, pp. 1049–1060, 1988. View at Publisher · View at Google Scholar
  29. D. R. Cox, “Regression models and life-tables,” Journal of the Royal Statistical Society B, vol. 34, no. 2, pp. 187–220, 1972. View at Google Scholar
  30. L. J. Wei, D. Y. Lin, and L. Weissfeld, “Regression analysis of multivariate incomplete failure time data by modelling marginal distributions,” Journal of the American Statistical Association, vol. 84, pp. 1065–1073, 1989. View at Google Scholar
  31. H. Minkoff, J. G. Feldman, H. D. Strickler et al., “Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women,” The Journal of Infectious Diseases, vol. 189, no. 10, pp. 1821–1828, 2004. View at Publisher · View at Google Scholar
  32. C. Bierl, K. Karem, A. C. Poon et al., “Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study,” Gynecologic Oncology, vol. 99, no. 3, supplement 1, pp. S262–S268, 2005. View at Publisher · View at Google Scholar
  33. M. C. Lopez and R. R. Watson, “Effect of cocaine and murine AIDS on lamina propria T and B cells in normal mice,” Life Sciences, vol. 54, no. 9, pp. PL147–PL151, 1994. View at Publisher · View at Google Scholar
  34. H. Minkoff, L. Ahdieh, L. S. Massad et al., “The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women,” AIDS, vol. 15, no. 16, pp. 2157–2164, 2001. View at Publisher · View at Google Scholar